Richard Kim, MD - From Trial Protocol to Routine Practice: Evaluating Real-World Evidence for Later-Line Treatments in Advanced Colorectal Cancer

Visit https://www.peervoice.com/JQC860 to view the entire programme with slides. After completing “Richard Kim, MD - From Trial Protocol to Routine Practice: Evaluating Real-World Evidence for Later-Line Treatments in Advanced Colorectal Cancer”, participants will be able to: Identify the key differences between clinical-trial data and real-world evidence (RWE); Evaluate available RWE related to the later-line treatment of advanced colorectal cancer (CRC); and Apply both clinical-trial data and RWE when designing regimens for patients with advanced CRC.